Candriam Luxembourg S.C.A. Sells 527,115 Shares of NeoGenomics, Inc. (NASDAQ:NEO)

   2020-10-25 07:10

Candriam Luxembourg S.C.A. lowered its position in NeoGenomics, Inc. (NASDAQ:NEO) by 93.8% during the 3rd the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,983 shares of the medical research company’s stock after selling 527,115 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in NeoGenomics were worth $1,290,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their p…




Original Source